Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naltrexone for acute whiplash injury
ACTRN12617000274370Phase 2Not yet recruiting
- Sponsor
- University of Notre Dame Australia
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Whiplash Associated Disorder (WAD) comparing Low-dose naltrexone with Placebo (2 arms). Primary endpoints: Numerical pain score responder rate at end of treatment, Neck Disability Index responder rate at end of treatment and 1 more. Planned start Sep 2017; status: not yet recruiting.
02
Drugs
naltrexone
03
Conditions
Whiplash Associated Disorder (WAD)
Beyond the preview
Go deeper on ACTRN12617000274370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000274370.